You are here

  • Home
  • Archive
  • Volume 30, Issue 5
  • Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments

Article metrics

Article menu
Download PDFPDF
Original research
Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2024

AbstractFullPdf
Mar 20205012214
Apr 2020771139
May 20208152119
Jun 202020353
Jul 202017133
Aug 202011222
Sep 202010712
Oct 202010221
Nov 20209934
Dec 202012674
Jan 202113221
Feb 202112032
Mar 202114445
Apr 202123485
May 20218453
Jun 2021100
Jul 2021311
Aug 2021510
Sep 2021411
Oct 20218511
Nov 20219200
Dec 20216833
Jan 202212820
Feb 20227932
Mar 202211623
Apr 20228310
May 20228922
Jun 202211931
Jul 20226640
Aug 20227362
Sep 202211312
Oct 20229751
Nov 20226211
Dec 20229421
Jan 20236800
Feb 20239600
Mar 202311900
Apr 20238310
May 20236100
Jun 20237700
Jul 20238476
Aug 20237342
Sep 20237800
Oct 20238131
Nov 20236863
Dec 20238544
Jan 202410400
Feb 202412010
Mar 202416811
Apr 20242800
Total6491167115